Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Curaleaf Holdings ( (TSE:CURA) ) just unveiled an announcement.
Curaleaf reported preliminary unaudited fourth-quarter 2025 net revenue of at least $330 million, representing about 4% sequential growth and 1% year-over-year growth, with adjusted gross profit margin expected at roughly 48.5% for the quarter and 50% for the full year. The company is discontinuing its hemp division in response to stricter U.S. federal limits on hemp-derived THC and exiting the Missouri market due to its sub-scale position there, moves that streamline operations around higher-conviction markets as management cites the success of its “Return to Our Roots” strategy and prepares to refinance senior secured notes due December 2026.
The most recent analyst rating on (TSE:CURA) stock is a Hold with a C$4.00 price target. To see the full list of analyst forecasts on Curaleaf Holdings stock, see the TSE:CURA Stock Forecast page.
Spark’s Take on TSE:CURA Stock
According to Spark, TipRanks’ AI Analyst, TSE:CURA is a Neutral.
Curaleaf Holdings’ overall stock score is driven by a mix of financial challenges and technical strengths. The company’s financial performance is hindered by declining revenue and profitability, along with increased leverage. However, positive cash flow generation provides some stability. Technical analysis shows a positive trend, contributing to a higher score. Valuation remains a concern due to ongoing losses. The earnings call highlights international growth, but domestic challenges persist.
To see Spark’s full report on TSE:CURA stock, click here.
More about Curaleaf Holdings
Curaleaf Holdings is a leading international cannabis company that produces and sells consumer cannabis products across medical and adult-use markets. Through brands such as Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company, it operates across the full supply chain and leverages a broad distribution network spanning Europe, Canada and Australasia, emphasizing scale, product quality and accessibility.
YTD Price Performance: 8.21%
Average Trading Volume: 1,041,142
Technical Sentiment Signal: Sell
Current Market Cap: C$2.85B
For a thorough assessment of CURA stock, go to TipRanks’ Stock Analysis page.